by Esme Fowler-Mason | Jan 22, 2025 | Behind the Scenes
Say hello to Dhruv, our Data Catalogue Manager and Financial Master Data Integrity Specialist from Mumbai, India. With a love for coding, cricket, and hip-hop, Dhruv brings both technical expertise and a vibrant energy to our mission of improving Global Health through...
by Esme Fowler-Mason | Dec 17, 2024 | NCD Case Studies, NCD Partnerships, News
Following the agreement on a new licensing model between the Medicines Patent Pool (MPP) & Novartis in collaboration with the ATOM Coalition, generic, quality-assured nilotinib is now available on NCDconnect! This initiative is crucial in making lifesaving...
by Esme Fowler-Mason | Dec 16, 2024 | NCD Solutions, News
Welcome to NCDconnect, your Digital Procurement Platform for essential medicines and medical devices against noncommunicable diseases (NCD). Signing up is straightforward, and this guide will help you complete the process with ease. Who can Use NCDconnect’s...
by Esme Fowler-Mason | Dec 13, 2024 | Access to Care, NCD Solutions, News
Every child deserves a fighting chance against cancer, regardless of where they are born. Yet, stark inequalities persist in access to pediatric oncology treatment, especially in low- and middle-income countries (LMICs). As purchasers responsible for securing...
by Esme Fowler-Mason | Dec 9, 2024 | Access to Care, NCD Solutions, News
Sickle Cell Disease (SCD) is a genetic blood disorder that affects millions of people worldwide. Between 2010 and 2050, an estimated 14 million babies will be affected globally, with the vast majority born in low- and middle-income countries (LMICs). This staggering...
